REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 20.00 (4.167%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 490.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Global Expansion

16 Jun 2008 07:00

RNS Number : 7214W
BrainJuicer Group PLC
16 June 2008
 



Press Release 

16 June 2008

BrainJuicer Group PLC

("BrainJuicer" or "the Company")

BrainJuicer furthers global expansion with 

Australian licence and Swiss office opening

 

 

BrainJuicer Group PLC, (AIM: BJU), a leading international online market research agencytoday announces that it has furthered its global expansion strategy by establishing a presence in both Australia and Switzerlandwhere a number of its existing and potential multinational clients have a regional head office. This expansion builds on the Company's existing offices in the UK, US and the Netherlands 

Australian licence agreement 

BrainJuicer has agreed to license its products to Slater Marketing Group Pty Ltd ("Slater"), a long-established market research firm based in Melbourne. This first strategic licensing deal for BrainJuicer has been driven by the importance of Australia for the Company's multinational clients. The agreement provides an opportunity to generate new revenues for BrainJuicer in the region, and there are a number of existing clients there already benefiting from BrainJuicer's innovative products, including Fosters Group, Fonterra (one of the largest dairy companies in Australia), and Campbell Arnott's

The licence agreement allows Slater to sell BrainJuicer's services in Australia and New Zealand on a profit share arrangement, which will lead to the acquisition of Slater dependent on a series of financial targets. The Company has purchased 3.64% of Slater and agreed to purchase the remainder of the business once pre-agreed financial targets have been metfor a total consideration of AU$2.2 million. The staged structure of the transaction allows BrainJuicer to enter this new market in a phased manner.

Swiss office opening

The Company also announces today that it is opening an office in Switzerlandwhich is a key strategic market for BrainJuicer's continued expansion.

BrainJuicer has appointed Mark Johnson as the country manager in order to build on the Company's existing client base in this territory. Mark has over 10 years' experience in consumer insight and market researchand with his strong track record of innovation he will be building a team to service Swiss-based clients. He has worked for research and innovation consultancies first in Londonthen Paris and most recently for Cereal Partners Worldwide in Lausanne (the joint venture between Nestlé and General Mills)By opening this office the Company will be in a position to tap into the significant number of multi-national companiewhich have theiEuropean heaofficelocated there.

John Kearon, CEO of BrainJuicer, commented: "We are delighted to announce the further expansion of the business, which reinforces BrainJuicer's strategy of broadening our geographical reach by identifying regions in which our existing and potential clients have regional head offices, and therefore aligning ourselves with these large multinational companies. Slater is an ideal fit for BrainJuicer, both in terms of its ethos and its client base. The agreement will have considerable benefit for both parties, as BrainJuicer's innovative products will enhance Slater's current offering, and Slater will give BrainJuicer access to this new territory.

"The opening of the Swiss office marks a significant step in terms of our presence in Europe. We have chosen a region in which we already have a number of clients and which houses the European head offices of many of the world's largest companies, including Nestle, General Mills, Proctor & Gamble, Roche and Philip Morris.  Our physical presence there will give us greater ability to grow our client base, and we are delighted to have attracted someone of Mark's calibre to establish this officehis strategic marketing approach will be of great benefit to the Company, and we look forward to his contribution to the ongoing innovation within BrainJuicer.

"The Board is excited about expanding BrainJuicer's global operations. We look forward to updating the market on the successful rollout of the licence agreement with Slater, as well as the anticipated growth of the Swiss office."

- Ends -

 

For further information, please contact:

BrainJuicer plc

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000 

James Geddes, Chief Financial Officer

www.brainjuicer.com

Landsbanki Securities (UK) Limited

Nomad & Broker

Fred Walsh / Simon Brown

Tel: +44 (0)20 7426 9000

 

www.landsbanki.co.uk 

UK media enquiries:

Abchurch Communications

Tel: +44 (0) 20 7398 7700

Heather Salmond / Joanne Shears

Tel: +44 (0) 20 7398 7709

joanne.shears@abchurch-group.com

www.abchurch-group.com 

US media enquiries:

BrainJuicer plc

Susan Griffin, VP Marketing and Business Development

Tel: +191 72 168 940

Notes to Editors

BrainJuicer carries out quantitative online research using innovative, bespoke software to produce insightful market research for large, multinational companies, including 15 of the world's top 100 companies (FT 500 September 2006).

BrainJuicer operates in a growing sector of the US$25bn global research market, namely quantitative online research. BrainJuicer's main competitors are large traditional market research providers who have dominated the market for off-line market research, such as AC Nielsen, Millward Brown, Research International and Taylor Nelson Sofres.

Whilst the largest traditional research companies have developed their own online capability, BrainJuicer has a number of key attributes which have contributed to it achieving rapid growth and winning contracts with prestigious clients, including:

• Research platform that delivers greater diagnostic insight. BrainJuicer has developed tools and award-winning techniques that enable it to provide a greater level of qualitative diagnostic insight into quantitative market research. These techniques enable clients to enhance their understanding of consumer preference and help them make decisions on the best way to develop their products and services.

• Speed. BrainJuicer's automated research techniques enable it to conduct complicated studies very quickly. BrainJuicer's rapid deployment and results production, even on multi-country studies, provide clients with a speed to market advantage in the development of new products and services.

• A scaleable online-only business model. Unlike the traditional research companies who maintain both on and offline data collection capabilities, BrainJuicer is able to focus on operating a scaleable online-only business model.

To date the Group has conducted projects in over 50 countries and more than 30 languages and has established offices in the UK, the Netherlands and the US.

The Group's revenues come from full service market research work, and from its online Juicy Brains Panel in the UK.

Further information on BrainJuicer can be found at www.brainjuicer.com .

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFWFIDSASELM
Date   Source Headline
16th Apr 20247:00 amRNSTrading Update
24th Jan 20247:00 amRNSTrading Update
12th Dec 202312:51 pmRNSPresentation via Investor Meet Company
6th Dec 20237:00 amRNSChange of Auditor
6th Dec 20237:00 amRNSInterim Results
24th Oct 20237:00 amRNSTrading Update
27th Sep 20236:00 pmRNSResult of AGM
27th Sep 20237:00 amRNSTrading Update
31st Aug 20237:00 amRNSAnnual Report and Notice of AGM
1st Aug 20237:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2023
31st Jul 20232:00 pmRNSPreliminary Results Presentation
13th Jul 20237:30 amRNSTrading update
30th Jun 20239:00 amRNSResolution of Complaint for Trademark Infringement
28th Jun 202311:00 amRNSHolding(s) in Company
3rd May 20233:15 pmRNSFurther re Result of General Meeting
21st Apr 202311:56 amRNSResult of General Meeting
13th Apr 20237:00 amRNSFurther re Requisitioned General Meeting
12th Apr 20237:00 amRNSTrading Update
5th Apr 202310:45 amRNSNotice of Trading Update
24th Mar 20234:00 pmRNSPosting of Circular and Notice of Requisitioned GM
24th Mar 20237:00 amRNSPosting of Circular and Notice of Requisitioned GM
7th Mar 20237:30 amRNSReceipt of Requisition Notice
28th Feb 202312:50 pmRNSCapital Markets Day
23rd Feb 20237:00 amRNSTrading Update
14th Feb 20237:00 amRNSCapital Markets Day
13th Jan 20232:00 pmRNSDirector/PDMR Shareholding
10th Jan 202310:30 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 20224:00 pmRNSDirector/PDMR Shareholding
13th Dec 20226:25 pmRNSDirector/PDMR Shareholding
6th Dec 20224:15 pmRNSDirectorate Change
30th Nov 20227:00 amRNSInterim Results
25th Oct 20227:00 amRNSTrading Update
28th Sep 20226:15 pmRNSResult of AGM
31st Aug 202211:00 amRNSNotice of AGM
31st Aug 20227:00 amRNSDirectorate Change
31st Aug 20227:00 amRNSReview of strategic options
30th Aug 20226:00 pmRNSTransaction in Own Shares
19th Aug 20228:55 amRNSTransaction in Own Shares
3rd Aug 20225:45 pmRNSTransaction in Own Shares
2nd Aug 20223:45 pmRNSTransaction in Own Shares
29th Jul 20229:30 amRNSTransaction in Own Shares
26th Jul 20226:24 pmRNSTransaction in Own Shares
19th Jul 20224:00 pmRNSHolding(s) in Company
19th Jul 20223:00 pmRNSTransaction in Own Shares
18th Jul 20224:30 pmRNSTransaction in Own Shares
15th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20227:00 amRNSShare Buyback Programme
12th Jul 20227:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2022
12th Jul 20227:00 amRNSQuarterly Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.